Home » Topics » BioWorld Science

BioWorld Science
RSS

NeoGenesis and Biogen expand small-molecule research alliance

July 11, 2001

Committee concludes positive interim safety review of tgAAVCF trial

July 11, 2001

FDA requests further data on Xolair, delaying approval

July 11, 2001

Pharmexa begins phase I/II trial of therapeutic vaccine for breast cancer in Denmark

July 11, 2001

CS-747 emerges as a useful antiplatelet agent for thrombotic disorders

July 11, 2001

ISTH news: antiplatelet/anticoagulant effects of PI-88 characterized

July 11, 2001

Ivax boosts immunotoxin program with new agreement

July 11, 2001

Antithrombin and antithrombotic effects of LB-30057 discussed at ISTH meeting

July 11, 2001

Novel anticoagulant targets surface-bound thrombin, may be preferable to heparin

July 11, 2001

Orally active gpIIb/IIIa antagonist shows broad-spectrum antiplatelet effects

July 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...